ArticleCureus2025
Effect of Non-surgical Periodontal Therapy on the Salivary Resistin Level in Obese and Non-obese Individuals With Periodontitis.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background The bidirectional relationship between obesity and periodontitis has been well-established, and adipokines play a key role in this association. Among adipokines, salivary resistin has been relatively less studied as a potential marker of systemic inflammation in obese individuals with periodontitis. With the increasing burden of lifestyle diseases, understanding the effects of periodontal therapy on the systemic inflammatory status of obese individuals will aid in more comprehensive health management. Therefore, this study aimed to compare salivary resistin levels and periodontal parameters before and 12 weeks after non-surgical periodontal therapy (NSPT) in obese and non-obese individuals with generalized stage II grade B periodontitis. Methods This longitudinal study included 60 participants with periodontitis. Participants were divided into two groups based on body mass index (BMI): the obese group (Group I) with BMI ≥ 27.5 kg/m² and the non-obese group (Group II) with BMI ≤ 27.5 kg/m². At baseline, salivary resistin levels and periodontal parameters, including probing pocket depth (PPD), clinical attachment level (CAL), full mouth plaque score (FMPS), and full mouth bleeding score (FMBS), were assessed. All participants underwent NSPT, with no local or systemic antibiotics or adjunctive treatments. Salivary resistin levels and periodontal parameters were reassessed 12 weeks post-treatment. Results Intergroup comparisons revealed higher resistin levels and periodontal parameters in the obese group at baseline and at the 12-week follow-up. Both groups showed a significant reduction in salivary resistin levels and clinical parameters after NSPT (p value<0.05). Even though the obese group demonstrated a greater magnitude of improvement in several measures, including salivary resistin, FMPS and FMBS after NSPT (p value<0.05), the values remain high compared to the non-obese group. Moreover, the non-obese group demonstrated a significant reduction in THE PPD and CAL indicating a pronounced clinical recovery following NSPT (p value<0.05). Conclusion Obesity contributes significantly to the severity of periodontitis by enhancing systemic inflammatory burden. NSPT effectively improved clinical periodontal health and reduced salivary resistin levels in individuals with periodontitis, regardless of obesity status. The obese group demonstrated more significant changes in salivary resistin levels following NSPT, but the clinical recovery in terms of PPD and CAL was better for the non-obese group. This study underscores the importance of integrating personalized periodontal care in obese individuals, along with other strategies aimed at reducing obesity associated inflammation to optimize long-term health outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.